These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG. Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan. Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547 [TBL] [Abstract][Full Text] [Related]
4. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)]. Knopf B; Wätzig V; Knöll B Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194 [TBL] [Abstract][Full Text] [Related]
5. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma. Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma. Jansen HM; The TH; Orie NG Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726 [TBL] [Abstract][Full Text] [Related]
7. Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer. Schulof RS; Mai D; Nelson MA; Paxton HM; Cox JW; Turner ML; Mills M; Hix WR; Nochomovitz LE; Peters LC Mol Biother; 1988; 1(1):30-6. PubMed ID: 2855788 [TBL] [Abstract][Full Text] [Related]
10. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Vermorken JB; Claessen AM; van Tinteren H; Gall HE; Ezinga R; Meijer S; Scheper RJ; Meijer CJ; Bloemena E; Ransom JH; Hanna MG; Pinedo HM Lancet; 1999 Jan; 353(9150):345-50. PubMed ID: 9950438 [TBL] [Abstract][Full Text] [Related]
12. Immunological responsiveness and adjunct immunotherapy in lung cancer. Fukushima M; Machida S; Kakuta H; Nishikawa T; Kikuchi A; Takashima K; Ishioka T; Ishikawa Y Jpn J Surg; 1978 Dec; 8(4):300-7. PubMed ID: 732053 [TBL] [Abstract][Full Text] [Related]
13. Mantoux, DNCB test, peripheral blood phagocyte activity and serum immunoglobulin levels in BCG vaccination treatment of lung tumor patients. Prugberger E; Hegyi P; Drinóczy M Dev Biol Stand; 1986; 58 ( Pt A)():395-9. PubMed ID: 3596045 [No Abstract] [Full Text] [Related]
14. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival. McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. Harris JE; Ryan L; Hoover HC; Stuart RK; Oken MM; Benson AB; Mansour E; Haller DG; Manola J; Hanna MG J Clin Oncol; 2000 Jan; 18(1):148-57. PubMed ID: 10623705 [TBL] [Abstract][Full Text] [Related]
16. Active specific and active non-specific immunotherapy in patients with malignant melanoma. Kokoschka EM; Cerni C; Micksche M Oncology; 1977; 34(5):229-33. PubMed ID: 917456 [TBL] [Abstract][Full Text] [Related]
17. Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth. Bakker W; Nijhuis-Heddes JM; Wever AM; Brutel de la Rivière A; van der Velde EA; Dijkman JH Thorax; 1981 Nov; 36(11):870-4. PubMed ID: 7330812 [TBL] [Abstract][Full Text] [Related]